Loading…

Role of Chlamydia in Multiple Sclerosis

Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biolo...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 2015-09, Vol.159 (5), p.646-648
Main Authors: Ivanova, M. V., Kolkova, N. I., Morgunova, E. Yu, Pashko, Yu. P., Zigangirova, N. A., Zakharova, M. N.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33
cites cdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33
container_end_page 648
container_issue 5
container_start_page 646
container_title Bulletin of experimental biology and medicine
container_volume 159
creator Ivanova, M. V.
Kolkova, N. I.
Morgunova, E. Yu
Pashko, Yu. P.
Zigangirova, N. A.
Zakharova, M. N.
description Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed. C. pneumoniae were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations. C. trachomatis was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by C. pneumoniae in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.
doi_str_mv 10.1007/s10517-015-3037-z
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785232174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A455405128</galeid><sourcerecordid>A455405128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</originalsourceid><addsrcrecordid>eNqNkU1rHDEMhk1oaDZpf0AuZSGQ9DKp5c-ZY1j6BSmFfJyN12NnHTzj7XjmkPz6atm0bEoCxQcj6XklpJeQY6DnQKn-VIBK0BUFWXHKdfW4R2YgNa9qxuANmVGEKlHX9QE5LOV-E1IFb8kBU0LVlIkZObvKyc9zmC9WyXYPbbTz2M9_TGmMayxcu-SHXGJ5R_aDTcW_f_qPyO2XzzeLb9Xlz6_fFxeXlcO5Y-Udb51rcBJvGQ8Ulg7nAJNtE4JrZBOUb4Fy22iMteI1SCWVa8QSlLecH5GP277rIf-afBlNF4vzKdne56kY0LVknIEW_4EqAbzhoBA9-Qe9z9PQ4yJIac4kE2KHurPJm9iHPA7WbZqaCyGlwGOzGqnzFyh8re-iy70PEfPPBKc7gpW3aVyVnKYx5r48B2ELOjx5GXww6yF2dngwQM3GcLM13KDhZmO4eUTNh6fNpmXn27-KPw4jwLZAwVJ_54ed1V_t-hvRIrBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1773252446</pqid></control><display><type>article</type><title>Role of Chlamydia in Multiple Sclerosis</title><source>Springer Nature</source><creator>Ivanova, M. V. ; Kolkova, N. I. ; Morgunova, E. Yu ; Pashko, Yu. P. ; Zigangirova, N. A. ; Zakharova, M. N.</creator><creatorcontrib>Ivanova, M. V. ; Kolkova, N. I. ; Morgunova, E. Yu ; Pashko, Yu. P. ; Zigangirova, N. A. ; Zakharova, M. N.</creatorcontrib><description>Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed. C. pneumoniae were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations. C. trachomatis was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by C. pneumoniae in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-015-3037-z</identifier><identifier>PMID: 26468024</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Antibodies ; Antibodies, Bacterial - blood ; Antibodies, Bacterial - cerebrospinal fluid ; Bacterial Typing Techniques ; Biomedical and Life Sciences ; Biomedicine ; Case-Control Studies ; Cell Biology ; Chlamydia ; Chlamydia infections ; Chlamydia Infections - blood ; Chlamydia Infections - cerebrospinal fluid ; Chlamydia Infections - microbiology ; Chlamydia Infections - pathology ; Chlamydia trachomatis - isolation &amp; purification ; Chlamydia trachomatis - physiology ; Chlamydophila pneumoniae ; Chlamydophila pneumoniae - isolation &amp; purification ; Chlamydophila pneumoniae - physiology ; DNA, Bacterial - blood ; DNA, Bacterial - cerebrospinal fluid ; Female ; Humans ; Immunoglobulin A - blood ; Immunoglobulin A - cerebrospinal fluid ; Immunoglobulin G - blood ; Immunoglobulin G - cerebrospinal fluid ; Immunoglobulin M - blood ; Immunoglobulin M - cerebrospinal fluid ; Internal Medicine ; Laboratory Medicine ; Male ; Middle Aged ; Multiple sclerosis ; Multiple Sclerosis - blood ; Multiple Sclerosis - cerebrospinal fluid ; Multiple Sclerosis - microbiology ; Multiple Sclerosis - pathology ; Pathology ; Pneumonia ; Severity of Illness Index</subject><ispartof>Bulletin of experimental biology and medicine, 2015-09, Vol.159 (5), p.646-648</ispartof><rights>Springer Science+Business Media New York 2015</rights><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</citedby><cites>FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26468024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivanova, M. V.</creatorcontrib><creatorcontrib>Kolkova, N. I.</creatorcontrib><creatorcontrib>Morgunova, E. Yu</creatorcontrib><creatorcontrib>Pashko, Yu. P.</creatorcontrib><creatorcontrib>Zigangirova, N. A.</creatorcontrib><creatorcontrib>Zakharova, M. N.</creatorcontrib><title>Role of Chlamydia in Multiple Sclerosis</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed. C. pneumoniae were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations. C. trachomatis was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by C. pneumoniae in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.</description><subject>Adult</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibodies, Bacterial - cerebrospinal fluid</subject><subject>Bacterial Typing Techniques</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Case-Control Studies</subject><subject>Cell Biology</subject><subject>Chlamydia</subject><subject>Chlamydia infections</subject><subject>Chlamydia Infections - blood</subject><subject>Chlamydia Infections - cerebrospinal fluid</subject><subject>Chlamydia Infections - microbiology</subject><subject>Chlamydia Infections - pathology</subject><subject>Chlamydia trachomatis - isolation &amp; purification</subject><subject>Chlamydia trachomatis - physiology</subject><subject>Chlamydophila pneumoniae</subject><subject>Chlamydophila pneumoniae - isolation &amp; purification</subject><subject>Chlamydophila pneumoniae - physiology</subject><subject>DNA, Bacterial - blood</subject><subject>DNA, Bacterial - cerebrospinal fluid</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin A - cerebrospinal fluid</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin G - cerebrospinal fluid</subject><subject>Immunoglobulin M - blood</subject><subject>Immunoglobulin M - cerebrospinal fluid</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - blood</subject><subject>Multiple Sclerosis - cerebrospinal fluid</subject><subject>Multiple Sclerosis - microbiology</subject><subject>Multiple Sclerosis - pathology</subject><subject>Pathology</subject><subject>Pneumonia</subject><subject>Severity of Illness Index</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkU1rHDEMhk1oaDZpf0AuZSGQ9DKp5c-ZY1j6BSmFfJyN12NnHTzj7XjmkPz6atm0bEoCxQcj6XklpJeQY6DnQKn-VIBK0BUFWXHKdfW4R2YgNa9qxuANmVGEKlHX9QE5LOV-E1IFb8kBU0LVlIkZObvKyc9zmC9WyXYPbbTz2M9_TGmMayxcu-SHXGJ5R_aDTcW_f_qPyO2XzzeLb9Xlz6_fFxeXlcO5Y-Udb51rcBJvGQ8Ulg7nAJNtE4JrZBOUb4Fy22iMteI1SCWVa8QSlLecH5GP277rIf-afBlNF4vzKdne56kY0LVknIEW_4EqAbzhoBA9-Qe9z9PQ4yJIac4kE2KHurPJm9iHPA7WbZqaCyGlwGOzGqnzFyh8re-iy70PEfPPBKc7gpW3aVyVnKYx5r48B2ELOjx5GXww6yF2dngwQM3GcLM13KDhZmO4eUTNh6fNpmXn27-KPw4jwLZAwVJ_54ed1V_t-hvRIrBI</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Ivanova, M. V.</creator><creator>Kolkova, N. I.</creator><creator>Morgunova, E. Yu</creator><creator>Pashko, Yu. P.</creator><creator>Zigangirova, N. A.</creator><creator>Zakharova, M. N.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20150901</creationdate><title>Role of Chlamydia in Multiple Sclerosis</title><author>Ivanova, M. V. ; Kolkova, N. I. ; Morgunova, E. Yu ; Pashko, Yu. P. ; Zigangirova, N. A. ; Zakharova, M. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibodies, Bacterial - cerebrospinal fluid</topic><topic>Bacterial Typing Techniques</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Case-Control Studies</topic><topic>Cell Biology</topic><topic>Chlamydia</topic><topic>Chlamydia infections</topic><topic>Chlamydia Infections - blood</topic><topic>Chlamydia Infections - cerebrospinal fluid</topic><topic>Chlamydia Infections - microbiology</topic><topic>Chlamydia Infections - pathology</topic><topic>Chlamydia trachomatis - isolation &amp; purification</topic><topic>Chlamydia trachomatis - physiology</topic><topic>Chlamydophila pneumoniae</topic><topic>Chlamydophila pneumoniae - isolation &amp; purification</topic><topic>Chlamydophila pneumoniae - physiology</topic><topic>DNA, Bacterial - blood</topic><topic>DNA, Bacterial - cerebrospinal fluid</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin A - cerebrospinal fluid</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin G - cerebrospinal fluid</topic><topic>Immunoglobulin M - blood</topic><topic>Immunoglobulin M - cerebrospinal fluid</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - blood</topic><topic>Multiple Sclerosis - cerebrospinal fluid</topic><topic>Multiple Sclerosis - microbiology</topic><topic>Multiple Sclerosis - pathology</topic><topic>Pathology</topic><topic>Pneumonia</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivanova, M. V.</creatorcontrib><creatorcontrib>Kolkova, N. I.</creatorcontrib><creatorcontrib>Morgunova, E. Yu</creatorcontrib><creatorcontrib>Pashko, Yu. P.</creatorcontrib><creatorcontrib>Zigangirova, N. A.</creatorcontrib><creatorcontrib>Zakharova, M. N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivanova, M. V.</au><au>Kolkova, N. I.</au><au>Morgunova, E. Yu</au><au>Pashko, Yu. P.</au><au>Zigangirova, N. A.</au><au>Zakharova, M. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Chlamydia in Multiple Sclerosis</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>159</volume><issue>5</issue><spage>646</spage><epage>648</epage><pages>646-648</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed. C. pneumoniae were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations. C. trachomatis was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by C. pneumoniae in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26468024</pmid><doi>10.1007/s10517-015-3037-z</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2015-09, Vol.159 (5), p.646-648
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_miscellaneous_1785232174
source Springer Nature
subjects Adult
Antibodies
Antibodies, Bacterial - blood
Antibodies, Bacterial - cerebrospinal fluid
Bacterial Typing Techniques
Biomedical and Life Sciences
Biomedicine
Case-Control Studies
Cell Biology
Chlamydia
Chlamydia infections
Chlamydia Infections - blood
Chlamydia Infections - cerebrospinal fluid
Chlamydia Infections - microbiology
Chlamydia Infections - pathology
Chlamydia trachomatis - isolation & purification
Chlamydia trachomatis - physiology
Chlamydophila pneumoniae
Chlamydophila pneumoniae - isolation & purification
Chlamydophila pneumoniae - physiology
DNA, Bacterial - blood
DNA, Bacterial - cerebrospinal fluid
Female
Humans
Immunoglobulin A - blood
Immunoglobulin A - cerebrospinal fluid
Immunoglobulin G - blood
Immunoglobulin G - cerebrospinal fluid
Immunoglobulin M - blood
Immunoglobulin M - cerebrospinal fluid
Internal Medicine
Laboratory Medicine
Male
Middle Aged
Multiple sclerosis
Multiple Sclerosis - blood
Multiple Sclerosis - cerebrospinal fluid
Multiple Sclerosis - microbiology
Multiple Sclerosis - pathology
Pathology
Pneumonia
Severity of Illness Index
title Role of Chlamydia in Multiple Sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A27%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Chlamydia%20in%20Multiple%20Sclerosis&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Ivanova,%20M.%20V.&rft.date=2015-09-01&rft.volume=159&rft.issue=5&rft.spage=646&rft.epage=648&rft.pages=646-648&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-015-3037-z&rft_dat=%3Cgale_proqu%3EA455405128%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1773252446&rft_id=info:pmid/26468024&rft_galeid=A455405128&rfr_iscdi=true